The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Inspections

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive mock FDA inspection services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Inspections

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Pediatric Analgesic OTCs To Be Discussed in Public Meeting

    It was just last week, on October 7, 2024, when we published a blog (...
    Read More
    Man Serving Ping Pong Ball

    After Lawsuit, FDA to Reconsider Tirzepatide Shortage Issue – the Saga Continues

    In late September, the FDA announced that Tirzepatide is no longer in ...
    Read More
    Paper clipboard with text POLICIES AND PROCEDURES.

    More Compounding News – Temporary Policy on Certain Parenteral Products

    As of October 10, 2024, pursuant to section 319(a) of the Public Healt...
    Read More
    FDA Grants Exemption to Connected Trading Partners - Lachman Blog

    FDA Grants Exemption to Connected Trading Partners

    Though the FDA had indicated previously that it would not extend the d...
    Read More
    Breaking news - world map background

    Follow-Up on GLP-1 Tirzepatide Compounding Story

    Just a brief follow-up on our post of October 3rd (here) regarding the...
    Read More

    FDA Warns of Triple-Threat Product Marketed as Dietary Supplement

    Well, there is bad, then there is worse!  In this case, the FDA warns...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today